Description
Validation of the innovative clinical endpoint capture methods in the pragmatic multi-center randomized trial "Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long- term Effectiveness (ADAPTABLE)"
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #02018-07-01$120,000
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2018-07-01(start date) | $120,000 | — | Validation of the innovative clinical endpoint capture methods in the pragmatic multi-center randomized trial… |
Related records · 2
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (exact legal name match; no business number on file)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 236-2025-2026-Q1-00974 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research | $6,972,975 | FY2026 |
| 236-2023-2024-Q3-00622 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research | $956,250 | FY2024 |
Cite as: Glassbox record view · Federal grants & contributions · 236-2018-2019-Q2-00464 · retrieved 2026-11-13.